# Quality of Life and Hormonal Impairment in Pediatric Patients With Craniopharyngiomas

**Authors:** Bárbara Pereira Neto, Ines Pais Cunha, Ana Laura Leite-Almeida, Sofia Ferreira, Janine Coelho, Rita Lago, Josué Pereira, Maria João Gil-da-Costa, Paulo Almeida, Cintia Castro-Correia

PMC · DOI: 10.7759/cureus.52621 · Cureus · 2024-01-20

## TL;DR

This study finds that children with craniopharyngiomas have lower quality of life compared to healthy peers, with hormonal issues and treatment types affecting outcomes.

## Contribution

The study identifies specific factors like hypothalamic involvement and subtotal resection that negatively impact quality of life in pediatric craniopharyngioma patients.

## Key findings

- Pediatric CP patients have lower Global, Physical, and Psychosocial Quality of Life scores compared to healthy Portuguese children.
- Hypothalamic involvement and subtotal resection are significant predictors of worse Quality of Life outcomes.
- Hormonal treatments for sexual hormones, adrenal insufficiency, and diabetes insipidus improve emotional and global Quality of Life.

## Abstract

Introduction: Craniopharyngiomas (CP) are tumors in the sellar region that, despite a high survival rate, are associated with significant morbidity, including hypothalamic, hormonal, and visual dysfunction. This study aimed to assess the quality of life (QoL) in pediatric patients with CP and to evaluate its relationship with various factors, with a focus on the impact of endocrine dysfunction.

Methods: In this observational cross-sectional study, patients with CP aged between 0 and 18 years, currently followed up in a tertiary hospital by a multidisciplinary team, were included. QoL was assessed using the validated PEDS-QL4.0 questionnaire, which was administered to parents. This tool estimates Global QoL (QoL-G), further divided into Physical (QoL-P) and Psychosocial (QoL-PS) dimensions, including Emotional (QoL-Em), Social (QoL-S), and School (QoL-Sc) aspects. In Portugal, the estimated average QoL-G is 79.8, QoL-P is 83.5, and QoL-PS is 78.2. Variables studied included gender, current and diagnostic age, follow-up time, presence of hydrocephalus, hypothalamic involvement, type of resection (total or subtotal), radiotherapy, visual impairment, hormonal deficits, and therapy.

Results: The study included 11 patients with a median age of 15.2 years (interquartile ratio (IQR), 9.7-17.9 years) and a mean age at diagnosis of 9.3±4.1 years. Of these patients, 54.5% were male, and 36.4% were obese. Subtotal resection was performed in 72.7% of cases. Hydrocephalus was present in 54.5% of the patients, hypothalamic involvement in 63.7%, radiotherapy was received by 81.8%, and visual impairment was noted in 54.5%. All patients presented with at least one hormonal deficit. The average QoL-G was 69.9±22.5, with QoL-P at 66.9±30.0 and QoL-PS at 70.9±21.4. A worse QoL-S was associated with female gender (p=0.030) and subtotal resection (p=0.048). Worse QoL-G, QoL-P, QoL-Em, and QoL-PS were linked to hypothalamic involvement (p values 0.008, 0.025, 0.015, and 0.009, respectively). Irradiated patients had worse QoL-G (p=0.006). Treatment with sexual hormones enhanced QoL-Global (p=0.035) and QoL-Emotional (p=0.020), while treatment for adrenal insufficiency and diabetes insipidus improved QoL-Emotional (p=0.021 and p=0.013). No significant associations with visual deficit or obesity were found.

Conclusions: Pediatric patients with CP appear to have poorer QoL-G, QoL-P, and QoL-PS compared to the healthy Portuguese population. However, the small sample size limits statistically significant associations with many of these variables. Predictors of worse QoL include female gender, hypothalamic involvement, subtotal resection, and radiotherapy. The results may be biased due to the small sample size, questionnaire administration to parents, and possible inadequacy of the questionnaire for the studied population. There is a need for a more suitable tool to enable a more precise assessment of QoL in these patients.

## Linked entities

- **Diseases:** hydrocephalus (MONDO:0001150), adrenal insufficiency (MONDO:0000004), diabetes insipidus (MONDO:0004782)

## Full-text entities

- **Diseases:** endocrine dysfunction (MESH:D004700), CP (MESH:D003397), hypothalamic, hormonal, and visual dysfunction (MESH:D014786), Hydrocephalus (MESH:D006849), tumors (MESH:D009369), obese (MESH:D009765), diabetes insipidus (MESH:D003919), Hormonal Impairment (MESH:C565870), hormonal deficits (MESH:D009461), adrenal insufficiency (MESH:D000309)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10875977/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC10875977/full.md

---
Source: https://tomesphere.com/paper/PMC10875977